Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas L Williams

Showing results (51-60 of 58) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 58 results.
British Journal of Pharmacology|February 3, 2019
A novel cyclic biased agonist of the apelin receptor, MM07, is disease modifying in the rat monocrotaline model of pulmonary arterial hypertensionPeiran Yang, Cai Read, Rhoda E Kuc, et al.
Cardiovascular Research|October 14, 2022
Inducible apelin receptor knockdown reduces differentiation efficiency and contractility of hESC-derived cardiomyocytesRobyn G C Macrae, Maria T Colzani, Thomas L Williams, et al.
ACS Nano|November 11, 2022
Machine Learning-Based Rapid Detection of Volatile Organic Compounds in a Graphene Electronic NoseNyssa S S Capman, Xue V Zhen, Justin T Nelson, et al.
Communications Biology|July 30, 2021
Human embryonic stem cell-derived cardiomyocyte platform screens inhibitors of SARS-CoV-2 infectionThomas L Williams, Maria T Colzani, Robyn G C Macrae, et al.
Nature Communications|December 27, 2024
Structural and functional determination of peptide versus small molecule ligand binding at the apelin receptorThomas L Williams, Grégory Verdon, Rhoda E Kuc, et al.
Nature Communications|May 13, 2025
ATP functions as a pathogen-associated molecular pattern to activate the E3 ubiquitin ligase RNF213Juraj Ahel, Arda Balci, Victoria Faas, et al.
Nature Communications|March 3, 2019
Dynamic pigmentary and structural coloration within cephalopod chromatophore organsThomas L Williams, Stephen L Senft, Jingjie Yeo, et al.
Nature|December 5, 2022
FXR inhibition may protect from SARS-CoV-2 infection by reducing ACE2Teresa Brevini, Mailis Maes, Gwilym J Webb, et al.
Pageof 6

Showing results (51-60 of 58) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 58 results.
British Journal of Pharmacology|February 3, 2019
A novel cyclic biased agonist of the apelin receptor, MM07, is disease modifying in the rat monocrotaline model of pulmonary arterial hypertensionPeiran Yang, Cai Read, Rhoda E Kuc, et al.
Cardiovascular Research|October 14, 2022
Inducible apelin receptor knockdown reduces differentiation efficiency and contractility of hESC-derived cardiomyocytesRobyn G C Macrae, Maria T Colzani, Thomas L Williams, et al.
ACS Nano|November 11, 2022
Machine Learning-Based Rapid Detection of Volatile Organic Compounds in a Graphene Electronic NoseNyssa S S Capman, Xue V Zhen, Justin T Nelson, et al.
Communications Biology|July 30, 2021
Human embryonic stem cell-derived cardiomyocyte platform screens inhibitors of SARS-CoV-2 infectionThomas L Williams, Maria T Colzani, Robyn G C Macrae, et al.
Nature Communications|December 27, 2024
Structural and functional determination of peptide versus small molecule ligand binding at the apelin receptorThomas L Williams, Grégory Verdon, Rhoda E Kuc, et al.
Nature Communications|May 13, 2025
ATP functions as a pathogen-associated molecular pattern to activate the E3 ubiquitin ligase RNF213Juraj Ahel, Arda Balci, Victoria Faas, et al.
Nature Communications|March 3, 2019
Dynamic pigmentary and structural coloration within cephalopod chromatophore organsThomas L Williams, Stephen L Senft, Jingjie Yeo, et al.
Nature|December 5, 2022
FXR inhibition may protect from SARS-CoV-2 infection by reducing ACE2Teresa Brevini, Mailis Maes, Gwilym J Webb, et al.
Pageof 6